The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency’s drug reviewers…
A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit…
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing…
Tooth loss is a risk factor for cognitive impairment and dementia—and with each tooth lost, the risk of cognitive decline grows, according to a new…
Gypsies and Travellers struggle to cope with dementia in family members, and are often in denial about a loved-one’s condition or try to hide it,…
Estrogen has been thought to play a role in a woman’s risk of developing Alzheimer disease (AD). A new study has taken a different approach…
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer’s disease amid considerable controversy should not be prescribed by…
During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to…
New research suggests one year of moderate-to-vigorous intensity aerobic exercise training improved cardiorespiratory fitness, cerebral blood flow regulation, memory and executive function in people with…
Frontotemporal dementia is the second most common cause of dementia in the working age population. Its diagnostics are complicated by the similar symptoms presented by…